Showing articles whose micro-themes are very close to:
#Inmazeb approval
- No closely related articles found yet.
- Brief review of Ebola virus disease and the One Health approach (pmc.ncbi.nlm.nih.gov) | 15d ago
- FDA Expands ERVEBO Approval to Children Aged 12 Months and Older (merck.com) | 14d ago
- FDA-Approved Ebola Treatment Ebanga (fda.gov) | 17d ago
- WHO Issues Updated Guideline on Therapeutics for Ebola Virus Disease (iris.who.int) | 14d ago
- FDA approves Ebanga (ansuvimab-zykl) for Zaire ebolavirus treatment (fda.gov) | 14d ago
- Ervebo vaccine: EMA EPAR summary for EU authorization (ema.europa.eu) | 14d ago
- Inmazeb (REGN-EB3) and Ebanga (Ansuvimab) monoclonal antibodies for Ebola treatment (youtube.com) | 14d ago
- Ring Vaccination with rVSV-ZEBOV-GP Significantly Reduces Ebola Incidence (2minutemedicine.com) | 17d ago
- Ervebo Vaccine: Efficacy and Deployment Against Zaire Ebolavirus (youtube.com) | 14d ago
- Evidence to Recommendations for rVSVΔG-ZEBOV-GP Ebola Vaccine (cdc.gov) | 17d ago
- WHO: Bundibugyo Ebola vaccine months away from human trials (nbcnews.com) | 20d ago
- WHO Technical Advisory Group recommends BDBV-specific vaccines as preferred, considers Ervebo for post-exposure use in Bundibugyo outbreak (iris.who.int) | 15d ago
- WHO advises against routine use of Ervebo vaccine for Bundibugyo virus outbreak, recommends research rather than programmatic deployment (iris.who.int) | 12d ago
- WHO selects vaccines, therapeutics for field trials against Ebola Bundibugyo outbreak in DRC (bioworld.com) | 11d ago
- WHO emergency guidance on licensed Ebola vaccine use during Bundibugyo virus disease outbreaks (who.int) | 12d ago
- WHO Advisory Group Recommends Maftivimab for Clinical Trials in Bundibugyo Ebola Outbreak (rttnews.com) | 11d ago
- Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114 (pmc.ncbi.nlm.nih.gov) | 17d ago
- rVSV-ZEBOV (Ervebo) Vaccine: Comprehensive Overview (en.wikipedia.org) | 14d ago
- Regeneron Secures $125M for Antibody-Helicon Conjugates; EMA Accepts Otarmeni MAA; Maftivimab Shows Lab Activity Against Bundibugyo Ebolavirus (tradingview.com) | 17d ago
- CDC Publishes ERVEBO Ebola Vaccine Product Information for Healthcare Providers (cdc.gov) | 14d ago
- Ebola Bundibugyo Outbreak in DRC and Uganda: Journal Article Summary and FDA-Approved Therapies Overview (guidelinecentral.com) | 20d ago
- Coalition for Epidemic Preparedness Innovations (CEPI) updates Ebola vaccine development progress (youtube.com) | 14d ago
Showing page 1 of 1
(22 total results)
← Prev
Next →